Insider Holders & Insider Ownership - Voyager Therapeutics Inc. (VYGR)

List of insiders holdings for Voyager Therapeutics Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
NEUROCRINE BIOSCIENCES INC
10% Owner
2023-02-24 06:15:528,575,316
0
8,575,316Form 13D
Third Rock Ventures III L.P.
Third Rock Ventures GP III L.P.
TRV GP III LLC
STARR KEVIN P
TEPPER ROBERT I
10% Owner
2019-02-13 16:02:026,457,874
0
6,457,874Form 13G
EcoR1 Capital LLC
10% Owner
2023-01-13 16:33:553,851,507
0
3,851,507Form 13G
Hadley Harbor Master Investors (Cayman) L.P.
10% Owner
2015-11-18 21:03:20470,588
0
470,588Form 4
Henderson Jane
Sr. V.P. & CFO, Corp. Dev.
2018-03-26 16:02:25342,368
0
342,368Form 4
Sandrock Alfred
President and CEO
2024-04-03 16:10:41322,839
0
322,839Form 4
Turenne Andre
President & CEO
2021-03-23 16:10:57322,375
0
322,375Form 4
Sah Dinah Ph.D.
Chief Scientific Officer
2019-01-17 20:51:14213,688
0
213,688Form 4
Third Rock Ventures III L.P.
Third Rock Ventures GP III L.P.
TRV GP III LLC
TEPPER ROBERT I
10% Owner
2024-02-14 16:19:07186,423
0
186,423Form 13G
PFREUNDSCHUH PETER P.
Chief Financial Officer
2024-02-22 16:32:59175,669
0
175,669Form 4
Fahey Sandell Jacquelyn
Chief Legal Officer
2024-02-16 17:06:56154,000
0
154,000Form 4
Khwaja Omar
See remarks
2021-05-25 16:31:13120,509
0
120,509Form 4
Swartz Robin
Chief Operating Officer
2024-04-03 16:13:27117,004
0
117,004Form 4
Dorval Allison
Chief Financial Officer
2021-03-23 16:10:28109,894
0
109,894Form 4
Ferguson Toby
Chief Medical Officer
2024-04-03 16:17:01105,000
0
105,000Form 4
Goater Jeff
Chief Financial Officer
2016-02-02 16:03:30105,000
0
105,000Form 4
Hesslein Robert W.
Senior VP & General Counsel
2023-03-22 16:47:41102,200
0
102,200Form 4
Carter Todd Alfred
Chief Scientific Officer
2024-02-22 16:30:5587,627
0
87,627Form 4
Burek Julie
VP, Finance
2022-03-23 18:36:4452,458
0
52,458Form 4
Ottmer Matthew P.
Chief Operating Officer
2020-01-29 17:26:5326,276
0
26,276Form 4
Hyman Steven
Director
2023-06-07 16:34:2122,000
0
22,000Form 4
SCANGOS GEORGE A
Director
2023-06-07 16:35:0822,000
0
22,000Form 4
GERAGHTY JAMES A
Director
2023-06-07 16:36:1522,000
0
22,000Form 4
Colon Grace
Director
2023-06-07 16:37:0722,000
0
22,000Form 4
Higgins Michael J
Director
2023-06-07 16:38:1022,000
0
22,000Form 4
Onyia Jude
Director
2023-06-07 16:39:1222,000
0
22,000Form 4
Vitale Nancy
Director
2023-06-07 16:40:0622,000
0
22,000Form 4
MACKEY CATHERINE J
Director
2023-06-07 16:40:5122,000
0
22,000Form 4
PIERCE GLENN
Director
2023-06-07 16:41:4222,000
0
22,000Form 4
PAUL STEVEN M
Director
2021-06-04 16:34:2615,000
0
15,000Form 4
KARSEN PERRY A
Director
2019-06-17 19:00:3615,000
0
15,000Form 4
DIXON WENDY L
Director
2020-06-05 16:16:3615,000
0
15,000Form 4
LEVIN MARK J
Director
10% Owner
2021-06-04 16:32:3415,000
0
15,000Form 4
Ravina Bernard
Chief Medical Officer
2018-04-12 16:01:230
0
0Form 4
Sanofi
Former 10% owner
2019-02-11 08:41:020
0
0Form 13G